Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization.
Henry A, Gordillo-Marañón M, Finan C, Schmidt AF, Ferreira JP, Karra R, Sundström J, Lind L, Ärnlöv J, Zannad F, Mälarstig A, Hingorani AD, Lumbers RT; HERMES and SCALLOP Consortia. Henry A, et al. Among authors: zannad f. Circulation. 2022 Apr 19;145(16):1205-1217. doi: 10.1161/CIRCULATIONAHA.121.056663. Epub 2022 Mar 18. Circulation. 2022. PMID: 35300523 Free PMC article.
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.
Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M; International AHFS Working Group. Felker GM, et al. Among authors: zannad f. Circ Heart Fail. 2010 Mar;3(2):314-25. doi: 10.1161/CIRCHEARTFAILURE.109.893222. Circ Heart Fail. 2010. PMID: 20233993 Review. No abstract available.
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study.
Rossignol P, Cleland JG, Bhandari S, Tala S, Gustafsson F, Fay R, Lamiral Z, Dobre D, Pitt B, Zannad F. Rossignol P, et al. Among authors: zannad f. Circulation. 2012 Jan 17;125(2):271-9. doi: 10.1161/CIRCULATIONAHA.111.028282. Epub 2011 Nov 29. Circulation. 2012. PMID: 22128223 Clinical Trial.
Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
Felker GM, Fiuzat M, Thompson V, Shaw LK, Neely ML, Adams KF, Whellan DJ, Donahue MP, Ahmad T, Kitzman DW, Piña IL, Zannad F, Kraus WE, O'Connor CM. Felker GM, et al. Among authors: zannad f. Circ Heart Fail. 2013 Nov;6(6):1172-9. doi: 10.1161/CIRCHEARTFAILURE.113.000207. Epub 2013 Oct 8. Circ Heart Fail. 2013. PMID: 24103327 Free PMC article. Clinical Trial.
Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
Rossignol P, Dobre D, McMurray JJ, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Messig M, Vincent J, Girerd N, Bakris G, Pitt B, Zannad F. Rossignol P, et al. Among authors: zannad f. Circ Heart Fail. 2014 Jan;7(1):51-8. doi: 10.1161/CIRCHEARTFAILURE.113.000792. Epub 2013 Dec 2. Circ Heart Fail. 2014. PMID: 24297687 Clinical Trial.
Geographic differences in heart failure trials.
Ferreira JP, Girerd N, Rossignol P, Zannad F. Ferreira JP, et al. Among authors: zannad f. Eur J Heart Fail. 2015 Sep;17(9):893-905. doi: 10.1002/ejhf.326. Epub 2015 Jul 21. Eur J Heart Fail. 2015. PMID: 26198782 Free article. Review.
Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration.
Ferreira JP, Girerd N, Arrigo M, Medeiros PB, Ricardo MB, Almeida T, Rola A, Tolpannen H, Laribi S, Gayat E, Mebazaa A, Mueller C, Zannad F, Rossignol P, Aragão I. Ferreira JP, et al. Among authors: zannad f. Medicine (Baltimore). 2016 Apr;95(14):e3307. doi: 10.1097/MD.0000000000003307. Medicine (Baltimore). 2016. PMID: 27057905 Free PMC article.
1,152 results